fundmomentum.vc

Fresenius Ventures

Germany
Series A
Share

About Fresenius Ventures

Fresenius has launched Fresenius Ventures, its corporate VC unit, deploying over 200 million euros over five years into healthcare adjacencies to its pharma, medtech and care-provision platforms: precision nutrition, microbiome research, new therapeutic modalities and digital care. Funded on-balance-sheet, led by ex-Angelini Ventures investor Thomas Thestrup.

Investment Focus

Location / RegionGermany
Funding StageSeries A
Industry Focus
Biotech
Digital Health

Investor Signals Profile

active

Sweet Spot

Healthcare-adjacency founder open to a strategic corporate investor, EU-relevant

corporate venture capital
healthcare adjacencies
precision nutrition
microbiome
digital care

Bullish Signals

EUR200M+ committed on-balance-sheet over 5 yearsexternal
Framed as core to group FutureFresenius strategyexternal

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Build a healthcare adjacency to pharma, medtech or care provision
Be open to a strategic corporate investor
Have EU relevance

Founder Don'ts

Expect the fast decision cycles typical of pure financial VCs

Key GPs & Partners

TT
Thomas Michael Thestrup
Managing Director & Head
corporate-VCscientist-dealmaker

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund Size€2.0K
Saves0

Key People

Thomas Michael Thestrup

Thomas Michael ThestrupManaging Director & Head

Related Funds

GIMIC Ventures Fund I

€100M
Germany
Pre Seed
Digital Health, Saas, Deep Tech, Climate Sustainability
Fund Manager:Alexander Rösner, Martin Sester, Mi Lê
Pre Seed
Digital Health
Saas
Deep Tech
Climate Sustainability

ZOHO.VC Fund I

€10M
Germany
Pre Seed
Deep Tech, Energy Tech, Med Tech
Fund Manager:ZOLLHOF
Pre Seed
Deep Tech
Energy Tech
Med Tech

Lucid Capital

€36M
Germany
Pre Seed
Ai Ml
Fund Manager:Johann Brenner, Srećko Tomić
Pre Seed
Ai Ml